Channing Capital Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Channing Capital Management’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-111,494	Closed	-$7.99M	–	115
2022 Q2	$7.99M	Sell	111,494 -58,704	-34%	-$4.29M	0.26%	81
2022 Q1	$13.8M	Buy	170,198 +17,750	+12%	+$1.5M	0.41%	53
2021 Q4	$15.7M	Buy	152,448 +6,566	+5%	+$631K	0.44%	52
2021 Q3	$12.8M	Buy	145,882 +83,373	+133%	+$7.55M	0.4%	60
2021 Q2	$5.59M	Buy	+62,509	New	+$5.28M	0.18%	105

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Channing Capital Management's SYNH Position: Q3 2022 in Review

Channing Capital Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2022, closing a stake of 111,494 shares — an estimated $7.99M sold.

Channing Capital Management first reported a position in SYNH in Q2 2021 and held it in 5 quarters. The position peaked at $15.7M in Q4 2021. 337 funds tracked by Wall St. Rank hold SYNH as of Q3 2022.

Channing Capital Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
Channing Capital Management sold 111,494 Syneos Health, Inc. Class A Common Stock shares in Q3 2022, an estimated $7.99M.
Channing Capital Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2021 and held it in 5 quarters.
Channing Capital Management's Syneos Health, Inc. Class A Common Stock position peaked at $15.7M in Q4 2021.
337 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2022.

Based on Channing Capital Management's 13F filing for Q3 2022, filed 8 Nov 2022.